IKT•benzinga•
Inhibikase Therapeutics Prices $4.0M Registered Direct Offering And Warrant Inducement Of 1,672,452 Shares Of Common Stock And 1,672,452 Unregisted Class B Warrants At Combined Purchase Price Of $1.68 Per Common Stock And Series A And B Warrant.
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 20, 2024 by benzinga